Trial List
List all clinical trials by discovery date. Accepts regular expressions in search.
GET /trials/?page=71
{ "count": 802, "next": "http://api.gregory-ms.com/trials/?page=72", "previous": "http://api.gregory-ms.com/trials/?page=70", "results": [ { "trial_id": 102, "title": "Tele-Assessment and Face-to-Face Evaluation of Functional Gait Assessment in Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: <br/><b>Sponsor</b>: Istanbul University-Cerrahpasa<br/><b>Recruiting</b>", "published_date": "2021-06-21T16:00:00Z", "discovery_date": "2021-06-21T20:04:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04932616?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 101, "title": "Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent", "summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Other: Siponimod<br/><b>Sponsor</b>: Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>", "published_date": "2021-06-21T16:00:00Z", "discovery_date": "2021-06-21T20:04:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04933552?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 103, "title": "Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: <br/><b>Sponsors</b>: Uğur OVACIK; Istanbul University-Cerrahpasa<br/><b>Not yet recruiting</b>", "published_date": "2021-06-21T16:00:00Z", "discovery_date": "2021-06-21T20:04:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04933110?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 98, "title": "The Gut Microbiome in Adult Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: <br/><b>Sponsor</b>: National MS Center Melsbroek<br/><b>Completed</b>", "published_date": "2021-06-17T16:00:00Z", "discovery_date": "2021-06-18T22:15:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04929145?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 100, "title": "Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS", "summary": "<b>Conditions</b>: Multiple Sclerosis; Cognitive Impairment<br/><b>Interventions</b>: Other: Intermittent theta burst stimulation (iTBS); Other: Sham Intermittent theta burst stimulation (iTBS)<br/><b>Sponsor</b>: University of Nottingham<br/><b>Not yet recruiting</b>", "published_date": "2021-06-18T16:00:00Z", "discovery_date": "2021-06-18T22:15:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04931953?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 99, "title": "Description of Adherence to the Main Preventive Health Campaigns of Persons With Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis<br/><b>Intervention</b>: Other: phone interview<br/><b>Sponsor</b>: University of Siena<br/><b>Recruiting</b>", "published_date": "2021-06-18T16:00:00Z", "discovery_date": "2021-06-18T22:15:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04930380?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 96, "title": "Safety and Effectiveness of Cinnomer® (Glatiramer Acetate) in Multiple Sclerosis (MS) Treatment in Iran", "summary": "<b>Condition</b>: Relapsing Multiple Sclerosis<br/><b>Intervention</b>: Drug: Glatiramer Acetate<br/><b>Sponsor</b>: Cinnagen<br/><b>Completed</b>", "published_date": "2021-06-16T16:00:00Z", "discovery_date": "2021-06-16T18:08:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04928313?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 97, "title": "Multiple Sclerosis and Voiding Symptoms: How to Assess?", "summary": "<b>Conditions</b>: Multiple Sclerosis; Lower Urinary Tract Symptoms; Voiding Disorders<br/><b>Intervention</b>: Other: voiding phase evaluation<br/><b>Sponsor</b>: Pierre and Marie Curie University<br/><b>Completed</b>", "published_date": "2021-06-16T16:00:00Z", "discovery_date": "2021-06-16T18:08:49Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04928716?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 95, "title": "Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis", "summary": "<b>Condition</b>: Multiple Sclerosis (MS)<br/><b>Interventions</b>: Drug: Fingolimod; Drug: Ofatumumab; Drug: Siponimod; Other: Fingolimod placebo; Other: Siponimod placebo; Other: Ofatumumab placebo<br/><b>Sponsor</b>: Novartis Pharmaceuticals<br/><b>Not yet recruiting</b>", "published_date": "2021-06-15T16:00:00Z", "discovery_date": "2021-06-15T16:34:48Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04926818?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null }, { "trial_id": 94, "title": "Study to Assess the Efficacy of Mayzent on Microglia in Secondary Progressive Multiple Sclerosis", "summary": "<b>Condition</b>: Secondary-progressive Multiple Sclerosis<br/><b>Interventions</b>: Drug: Mayzent; Drug: Ocrevus<br/><b>Sponsor</b>: Robert Zivadinov, MD, PhD<br/><b>Not yet recruiting</b>", "published_date": "2021-06-14T16:00:00Z", "discovery_date": "2021-06-14T17:57:48Z", "link": "https://clinicaltrials.gov/ct2/show/NCT04925557?cond=Multiple+Sclerosis&amp;sfpd_d=14&amp;sel_rss=new14", "source": "Clinical Trials.gov", "relevant": null } ] }